Literature DB >> 9673277

Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis.

G M Winslow1, E Yager, K Shilo, D N Collins, F K Chu.   

Abstract

To determine the basis of susceptibility and resistance to human monocytic ehrlichiosis (HME), immunocompetent and immunocompromised mice were infected with Ehrlichia chaffeensis and bacterial loads were measured by PCR and by immunohistochemistry. Immunocompetent (C. B-17 and C57BL/6) mice cleared the bacteria within 10 days, but immunocompromised SCID and SCID/BEIGE mice developed persistent infection in the spleen, liver, peritoneal cavity, brain, lung, and bone marrow and became moribund within 24 days. Both immunocompromised strains lack T and B lymphocytes, but the SCID/BEIGE strain is also deficient in natural killer (NK) cell function. During advanced stages of disease, the infections were associated with wasting, splenomegaly, lymphadenopathy, liver granulomas and necroses, intravascular coagulation, and granulomatous inflammation. Histochemical and immunohistochemical localization studies confirmed the presence of bacteria in tissues, and viable bacteria were cultured from infected animals. The data reveal that T and/or B cells play an essential role during resistance of immunocompetent mice to infection with E. chaffeensis and demonstrate the utility of immunocompromised mice as an experimental model for the study of HME.

Entities:  

Mesh:

Year:  1998        PMID: 9673277      PMCID: PMC108445     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.

Authors:  P S Kaylor; T B Crawford; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Identification of Ehrlichia in human tissue.

Authors:  J S Dumler; P Brouqui; J Aronson; J P Taylor; D H Walker
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

3.  An outbreak of ehrlichiosis in members of an Army Reserve unit exposed to ticks.

Authors:  L R Petersen; L A Sawyer; D B Fishbein; P W Kelley; R J Thomas; L A Magnarelli; M Redus; J E Dawson
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

Review 4.  Immunity to intracellular bacteria.

Authors:  S H Kaufmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions.

Authors:  R L Modlin; C Pirmez; F M Hofman; V Torigian; K Uyemura; T H Rea; B R Bloom; M B Brenner
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

6.  Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis.

Authors:  J S Dumler; J E Dawson; D H Walker
Journal:  Hum Pathol       Date:  1993-04       Impact factor: 3.466

7.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

Authors:  R P Custer; G C Bosma; M J Bosma
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

8.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Cloned L3T4+ T lymphocytes protect mice against Listeria monocytogenes by secreting IFN-gamma.

Authors:  D M Magee; E J Wing
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

10.  Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis.

Authors:  F K Chu
Journal:  Mol Cell Probes       Date:  1998-04       Impact factor: 2.365

View more
  33 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Authors:  David H Walker; Nahed Ismail; Juan P Olano; Jere W McBride; Xue-Jie Yu; Hui-Min Feng
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

3.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan.

Authors:  S Shibata; M Kawahara; Y Rikihisa; H Fujita; Y Watanabe; C Suto; T Ito
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis.

Authors:  Patricia A Crocquet-Valdes; Nagaraja R Thirumalapura; Nahed Ismail; Xuejie Yu; Tais B Saito; Heather L Stevenson; Colette A Pietzsch; Sunil Thomas; David H Walker
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

6.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 7.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 9.  Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

Authors:  Nasia Safdar; Robert B Love; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis.

Authors:  Katherine C MacNamara; Rachael Racine; Madhumouli Chatterjee; Dori Borjesson; Gary M Winslow
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.